Structured evidence table for Elderberry Immune Wellness Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Elderberry Immune Wellness Randomized Trial | A prospective cohort study of 428 couples in infertility clinics found that 29% of couples used a CAM modality for infertility treatment, with 17% specifically using herbal therapies over the course of 18 months (). | 4 | Friedman Julie (2023) | Herbal supplement use among reproductive-aged women in an academic infertility practice |
| Elderberry Immune Wellness Randomized Trial | Concurrent use of herbal medicines with prescription medications is reported among 20%–30% of prescription drug users in the United States; there is evidence via in vitro and in vivo studies that herbal therapies can act as metabolic inhibitors or inducers of prescription medications when used in combination (). | 4 | Friedman Julie (2023) | Herbal supplement use among reproductive-aged women in an academic infertility practice |
| Elderberry Immune Wellness Randomized Trial | Risks of herbal-drug interactions span from side effects (eg, bleeding, cardiotoxicity, hypoglycemia, hypotension) to altered pharmacokinetics (eg, decreased absorption, increased metabolism) of medications (). | 4 | Friedman Julie (2023) | Herbal supplement use among reproductive-aged women in an academic infertility practice |
| Elderberry Immune Wellness Randomized Trial | 1 1 2 3 4 The Center for Disease Control’s (CDC) 2017 National Health and Nutrition Examination Survey estimated that, on average, 57% of the United States population uses dietary supplements, with botanicals or “herbal supplements” comprising 5.1–8.3% of these supplements (). | 4 | Friedman Julie (2023) | Herbal supplement use among reproductive-aged women in an academic infertility practice |
Source documents